APA (7th ed.) Citation

Schaarschmidt, M., Herr, R., Schmieder, A., Sonntag, D., & Goerdt, S. (2015). Patient preferences for biologicals in psoriasis: Top priority of safety for cardiovascular patients. PLOS ONE, 10(12), . https://doi.org/10.1371/journal.pone.0144335

Chicago Style (17th ed.) Citation

Schaarschmidt, Marthe-Lisa, Raphael Herr, Astrid Schmieder, Diana Sonntag, and Sergij Goerdt. "Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients." PLOS ONE 10, no. 12 (2015). https://doi.org/10.1371/journal.pone.0144335.

MLA (9th ed.) Citation

Schaarschmidt, Marthe-Lisa, et al. "Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients." PLOS ONE, vol. 10, no. 12, 2015, https://doi.org/10.1371/journal.pone.0144335.